Tag Archives: revoke

Cipla restrained to make generic COPD drug: DHC

The Delhi High Court restrained domestic pharma company Cipla from producing and marketing a generic version of Novartis drug ‘Onbrez’ used for treating Chronic Obstructive Pulmonary Disease. Novartis sued Cipla for infringement of its Indian patents for drug ‘Onbrez’ containing Indacaterol … Continue reading

Posted in Intellectual Property Law, International Law, patent law, Trade Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Power of patent revocation discretionary u/S 64(1): DHC

The Delhi High Court recently ruled that the power of the Controller of Patents to revoke a patent under Section 64(1) of the Indian Patents Act, 1970 (“Act”) is discretionary and such revocation is not automatic. The Court said, “….. … Continue reading

Posted in Intellectual Property Law, International Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Transfer of possession not essential under a gift: SC

A Large Bench of the Supreme Court of India clarified that the ‘transfer of possession’ of immovable property under a gift is not an essential prerequisite under Transfer of Property Act (“Act”) and does not affect the validity of a … Continue reading

Posted in Civil Law, Contract Law, Family Law, General Law, Real Estate | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Revoked patent is not enforceable even though it remains on the Register: DHC

In an important patent law ruling, Delhi High Court held that once a patent has been revoked by an authority and no stay has been granted by the appellate authority, the said revoked patent is not enforceable even though it … Continue reading

Posted in Intellectual Property Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Cipla not infringing Pfizer patent for drug Tarceva: DHC

In a big relief to pharmaceutical company Cipla Ltd. (“Cipla”), the Delhi High Court ruled that Cipla did not infringe OSI/Pfizer (“Pfizer”) Indian patent for their drug ‘Erlotinib’ (trade name ‘Tarceva’) by manufacture, marketing and sale of their drug ‘Erlocip’, … Continue reading

Posted in Intellectual Property Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment